BioAge Labs, Inc.
BIOA
$4.13
-$0.07-1.67%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 38.81% | 9.73% | -72.35% | -4.53% | 38.01% |
| Total Depreciation and Amortization | -21.28% | 23.68% | -22.45% | 48.48% | -19.51% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 29.55% | 7.02% | 30.75% | -15.05% | -74.80% |
| Change in Net Operating Assets | -155.46% | 117.97% | 258.27% | 16.23% | -203.80% |
| Cash from Operations | -237.93% | 65.59% | 5.39% | -0.70% | -84.31% |
| Capital Expenditure | -1,538.46% | 91.48% | -771.43% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -299,853.85% | 91.48% | -771.43% | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | 0.00% | 0.00% | 0.00% | -50.00% |
| Issuance of Common Stock | -- | -85.76% | 45,914.69% | 13,966.67% | -25.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -100.00% | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 51.04% | -100.24% | -152.79% | -3,761.54% |
| Cash from Financing | -106.02% | -86.94% | 8,088.40% | -101.42% | 16,750.25% |
| Foreign Exchange rate Adjustments | -108.76% | 336.21% | -241.18% | -189.47% | 129.23% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -587.36% | -88.67% | 1,062.62% | -111.96% | 1,690.77% |